dental anxiety and management. Mental and behavioural disorders
Conditions
Interventions
Intervention 1: Intervention group 1 :In 1st session oral Midazolam suspension premedication (0.5mg/kg) is administered half an hour before IV Ketamin (2mg/kg) and IV Midazolam (0.5 mg/kg). Then in
Treatment - Drugs
Intervention group 1 :In 1st session oral Midazolam suspension premedication (0.5mg/kg) is administered half an hour before IV Ketamin (2mg/kg) and IV Midazolam (0.5 mg/kg). Then in 2nd session ora
Intervention group 2 : In 1st session oral Promethazine suspension premedication (0.5mg/kg) is administered half an hour before IV Ketamin (2mg/kg) and IV Midazolam (0.5 mg/kg). Then in 2nd sessi
Sponsors
Vice Chancellor of Research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: uncooperative children aged 2-6 years; completely negative Frankle behavioral scale; ASA I or II for systemic health; two teeth requiring the same treatment in two separate sessions Exclusion Criteria: any systemic disease with contraindication for sedation or premedication ;nasal obstruction;respiratory infection; mouth opening limitation; macroglossia; tonsillar hypertrophy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's Cooperation for Sedation. Timepoint: At the IV Administration step. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomitting. Timepoint: After the end of treatment and sedation. Method of measurement: Questionair.;Sleeepiness. Timepoint: After the end of treatment and sedation. Method of measurement: Questionair.;Dizziness. Timepoint: After the end of treatment and sedation. Method of measurement: Questionair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Zarghi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed